Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |